In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fusion Medical Technologies Inc.

Division of Baxter International Inc.
www.fusionmed.com

Latest From Fusion Medical Technologies Inc.

Concentric Medical: Breaking the Stroke Device Barrier

Concentric overcame major technology and regulatory challenges to be first to market in a large, complex device space, treating acute ischemic stroke, which has befuddled big companies and start-ups.
Medical Device Clinical Trials

Cutting Out the Knots in Surgery

The needle-and-thread suturing process surgeons use to create anastomoses has been a staple in the OR, largely unchallenged for nearly a century. New developments in minimally invasive and endoscopic surgery, particularly in coronary bypass procedures, have created the need for a tissue-closure technique that can produce high-quality anastomoses in small spaces with limited visualization. As a result, anastomotic device technology, a long dormant area of product development, has become a hot subject at clinical meetings, and numerous companies, from major device firms to start-ups, are exploring a range of different approaches. Coalescent Surgical, a start-up, is one of the first to market in this area, with an anastomotic device that uses an approach different than its competitors--a proprietary self-closing clip that replaces traditional sutures. Coalescent's challenge: to gain acceptance from surgeons, who are notoriously slow adopters of new technology. The company is betting that the advantages of its device, combined with being first to market, will enable it to survive what appears will be a stampede of competitors, including major players that have superior resources and existing relationships with surgeons.
Medical Device North America

Surgical Sealants: Is there a Cohesive Strategy?

Surgical sealants have promise, but can a host of companies convince surgeons that these adjunctive therapies are "need to have" not "nice to have" technologies?
Medical Device

Device Valuations: Private Profits, Public Losses

Recent medical device IPOs have fallen in value an average of 14%; but even at their current low valuations, returns to private investors remain healthy. For this reason, it is likely that new IPOs will be priced far closer to the valuations of the last private rounds than they were in the IPOs of 1996-97. This Start-Up analysis also reveals that, contrary to conventional industry wisdom, companies who went public with earlier stage products have generated higher returns to both private and public investors.
Medical Device Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Surgical Sealants
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Baxter International Inc.
  • Senior Management
  • Philip M Sawyer, Pres. & CEO
    Richard C Spalding, VP, Fin. & Corp. Dev. & CFO
    Gary A Curtis, EVP, Sales & Mktg.
    Cary J Reich, PhD, VP, R&D
  • Contact Info
  • Fusion Medical Technologies Inc.
    Phone: (415) 903-4000
    1615 Plymouth St.
    Mountain View, CA 94043
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register